Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2784984 | 0.80 | TSHR (0.43) | TSHR | |
| SCHEMBL965732 | 0.77 | CHRM1 (0.36) | TSHR | |
| SCHEMBL22443062 | 0.77 | TSHR (0.46) | TSHR | |
| SCHEMBL934694 | 0.76 | TSHR (0.40) | TSHR | |
| SCHEMBL17072311 | 0.73 | — | — | |
| SCHEMBL15349735 | 0.73 | — | — | |
| SCHEMBL760206 | 0.73 | — | — | |
| SCHEMBL28552922 | 0.73 | TSHR (0.37) | TSHRGRIN1GRIN2AGRIN2DGRIN2C | |
| SCHEMBL6543364 | 0.71 | — | — | |
| SCHEMBL3812042 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113423470-B | Cosmetic compounding agent, cosmetic, and method for producing same | 三吉油脂株式会社 | 2024-07-09 | — | — | CN | disclosed |
| US-20240218254-A1 | ADDITIVE FOR SURFACE ACTIVATION, AND EMULSION COMPOSITION USING SAME | MIYOSHI OIL & FAT CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| WO-2024142526-A1 | RUBBER COMPOSITION, LAMINATE, AND HOSE | 横浜ゴム株式会社 | 2024-07-04 | — | — | WO | disclosed |
| US-20240201055-A1 | CROSS-LINKED POLYMER, METHOD FOR SEPARATING SUBSTANCE, KIT FOR SEPARATING SUBSTANCE, KIT FOR TESTING FOR DISEASE, AND DEVICE FOR SEPARATING SUBSTANCE | SANYO CHEMICAL IND LTD (JP) | 2024-06-20 | — | — | US | disclosed |
| US-20240057587-A1 | ORGANIC AMMONIUM SALT AND HYDROGEN-BONDING MATERIAL TREATMENT AGENT USING SAME | MIYOSHI OIL & FAT CO.,LTD. (JP) | 2024-02-22 | — | — | US | disclosed |
| EP-4317399-A1 | CROSS-LINKED POLYMER, METHOD FOR SEPARATING SUBSTANCE, KIT FOR SEPARATING SUBSTANCE, KIT FOR TESTING FOR DISEASE, AND DEVICE FOR SEPARATING SUBSTANCE | Sanyo Chemical Industries, Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117295945-A | Crosslinked polymer, method for separating substance, kit for detecting disease, and device for separating substance | 三洋化成工业株式会社 | 2023-12-26 | — | — | CN | disclosed |
| CN-117203308-A | Additive for making interface active and emulsifying composition using the same | 三吉油脂株式会社 | 2023-12-08 | — | — | CN | disclosed |
| US-20230340356-A1 | ADDITIVE OR COMPOSITION FOR IMPARTING LUBRICITY | MIYOSHI OIL & FAT CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| EP-3766969-B1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | MIYOSHI YUSHI KK (JP) | 2023-10-04 | — | — | EP | disclosed |
| US-20170029801-A1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | MIYOSHI OIL & FAT CO., LTD. (JP) | 2017-02-02 | — | — | US | disclosed |
| EP-1585530-A4 | BIOADHESIVE PHARMACEUTICAL COMPOSITIONS | BARBEAU DONALD L (US) | 2009-09-09 | — | — | EP | disclosed |
| US-7119079-B2 | Bioadhesive pharmaceutical compositions | B&G PARTNERS LLC | 2006-10-10 | — | — | US | disclosed |
| EP-1585530-A2 | BIOADHESIVE PHARMACEUTICAL COMPOSITIONS | Barbeau, Donald L. (US) | 2005-10-19 | — | — | EP | disclosed |
| WO-2004064754-A2 | BIOADHESIVE PHARMACEUTICAL COMPOSITIONS | BARBEAU DONALD L (US) | 2004-08-05 | — | — | WO | disclosed |
| US-20040142880-A1 | Bioadhesive pharmaceutical compositions | B&G PARTNERS LLC | 2004-07-22 | — | — | US | disclosed |
| US-6699848-B1 | USEFUL FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | B&G PARTNERS LLC | 2004-03-02 | — | — | US | disclosed |
| WO-1997046543-A1 | ACETYL DERIVATIVES OF THIAZOLES AND ANALOGUES | THE UNIVERSITY OF WOLLONGONG (AU) | 1997-12-11 | — | — | WO | disclosed |
| US-4046893-A | ANALGESIC, ANTIPHLOGISTIC | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JA) | 1977-09-06 | — | — | US | disclosed |
| US-3946012-A | 6-L-dihydroxyethyl-2,4,7-trioxo-8-D-ribityl pteridine and process for producing the same | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JA) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142880-A1 | Bioadhesive pharmaceutical compositions | UGT1A10, APOL1, ALG1 | TSHR 3298/4885GRIN1 2595/4885GRIN2A 3108/4885 |
| US-20240057587-A1 | ORGANIC AMMONIUM SALT AND HYDROGEN-BONDING MATERIAL TREATMENT AGENT USING SAME | OR10J3, HCN4, CLIC4 | TSHR 4611/4885GRIN1 506/4885GRIN2A 1523/4885 |
| US-20240218254-A1 | ADDITIVE FOR SURFACE ACTIVATION, AND EMULSION COMPOSITION USING SAME | HAO2, NOTUM, FFAR2 | TSHR 2408/4885GRIN1 1319/4885GRIN2A 1110/4885 |
| US-20170029801-A1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | BCKDK, HACL2, HAO2 | TSHR 4368/4885GRIN1 2425/4885GRIN2A 4364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.